BVA President Gudrun Ravetz said: "Veterinary View not only highlights some of the veterinary profession's fantastic work, but complements our joint project with RCVS, Vet Futures, in exploring how the profession can best shape its own future. We hope it will stimulate debate among vets, and the wider community in which we work, about both the big challenges and opportunities that the veterinary profession is facing."
The series includes a number of videos which showcase more recent industry developments:
Stem Cell therapy for the treatment of canine osteoarthritis (VetCell Therapeutics)
Pharmtrax, a mobile device for vets to record work and dispensing on the farm (Henry Schein Animal Health)
Hormone implants as an alternative to castration (Virbac Animal Health)
Practice management support from Zoetis
Preventing an epidemic of equine flu (Merial Animal Health)
Procanicare contains three live strains of canine-specific Lactobacillus bacteria, which, according to the company, make it an ideal GI support product to maintain balance in the GI intestinal microbiome of dogs, particularly when an alteration to the intestinal microbiome is a risk.
Animalcare says studies show that the strains of Lactobacillus found in Procanicare have been shown to promote indigenous intestinal commensal populations, reduce numbers of potentially pathogenic bacteria and improve stool consistency.1,2
Dr Shea Beasley, Product Development Manager at Vetcare Ltd said: "The strains of Lactobacillus found in Procanicare have been commercially available in Scandinavia for two years now. It has achieved great success, with Scandinavian vets frequently recommending it in situations where the gastrointestinal microbiota can become unstable such as following antibiotic use and in stressful situations such as travelling and kennelling, as well as when supporting the intestinal microbiome is particularly important, such as during pregnancy and lactation."
Available exclusively through vets, Animalcare has produced a range of waiting room materials to help you educate about and promote Procanicare in practice, including a poster, bunting, leaflet and leaflet holder.
There is also a free webinar for veterinary professionals on the importance of the intestinal microbiome, available to view at www.thewebinarvet.com/webinar/the-gastrointestinal-microbiome-and-its-effects.
To find out more or to try Procanicare in your practice, contact your local Animalcare representative via email animalcare@animalcare.co.uk or telephone 01904 487687 or visit www.procanicare.com.
References
'The new discovery in feline communication' symposium was held during the ISFM (International Society of Feline Medicine) International Feline Congress from 8th - 10th August.
The symposium was presented by Professor Patrick Pageat DVM MSc PhD HDR Dipl ECAWBM-BM Hon Dipl CLECVe, who researched and developed both Feliway and Adaptil, and Dr Andy Sparkes BVetMed PhD DipECVIM MANZCVS MRCVS, veterinary consultant at ISFM.
Patrick presented ‘the science behind the new pheromone discovery’ and covered how it was developed, how it works and why it is a step up from the existing pheromone products. Andy followed with ‘Feliway Optimum: clinical evidence’ and featured the clinical data behind the new product and how it outperforms existing pheromones.
To register for ‘the new discovery in feline communication’ symposium on demand, which equates to one hour’s CPD, email cevauk@ceva.com.
The Blue Cross is calling for nominations from veterinary practices across the country for its Veterinary Nurse of the Year Award 2009.
The annual award is presented at the British Veterinary Nursing Association (BVNA) Annual Congress. It recognises the contribution of veterinary nurses in educating the public about responsible pet ownership and the welfare of pets in the community. This year's Congress will take place on 9-11 October at the Kettering Conference Centre, Northamptonshire.
Last year's award was won by Rebecca Darbyshire for her outstanding contribution to animal welfare, both within her veterinary practice and among the local community in Pocklington, York.
Rebecca Darbyshire was nominated by vet and colleague Matt Brash at Battlefields veterinary clinic in Pocklington.
Mr Brash said: "Rebecca is an outstanding, unassuming professional nurse. She runs all of the clinics that a modern day nurse does, but still has the time for anybody - whatever they need, whenever they need it. She has developed such a close relationship with our clients that they would often rather see her than a vet!"
Nominations for this year's award can be made by completing the nomination form on The Blue Cross website at: www.bluecross.org.uk/BVNA2009 or by contacting Sally Leathem on 01993 825577. The deadline for nominations is Friday 14 August 2009.
The Blue Cross has taken the lead in animal care for over a hundred years. Its four animal hospitals provide a lifeline for pet owners on low incomes. Its community vet services also cater for elderly and disabled people. Without the charity's hospitals, and the services they provide, many people would be without the benefits that pet ownership can bring.
The Fédération Équestre Internationale (FEI) has added Metacam for Horses to its 'list of detection times'.
According to the manufacturer, Boehringher Ingelheim Vetmedica, Metacam (meloxicam) is the first preferential COX-2 inhibitor to be added to this list, and has stated plasma and urine detection times of 72 hours administered intravenously or orally1. This is the shortest urine detection time of the NSAIDs available for use in horses, and compares to the 168-hour (7 days) detection time for phenylbutazone stated by the FEI.
Craig Beck, equine sales and marketing manager for Boehringer Ingelheim in the UK and Ireland said: "We have been very happy to work in partnership with the FEI to provide the robust data that has supported the FEI in their analysis of Metacam. Metacam is an important addition to the FEI list, that will help vets treating competition horses. There is now a modern and proven NSAID which extends the therapeutic options available to vets."
Metacam is licensed in horses for the alleviation of inflammation and relief of pain associated with musculo-skeletal disorders or colic.
For further information, please contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
1 Detection Time agreed with the European Horse Racing Scientific Liaison Committee (EHSLC)
The webinars each last between three and five minutes and are part of the 2016 ‘Talk About Laminitis’ disease awareness initiative to help detect, manage and monitor PPID.
The webinars can be viewed on the Boehringer Academy website – www.boehringer-academy.co.uk - and podcast versions are also available enabling veterinary professionals to listen to them ‘on the go’.
The first series includes:
The second webinar series covers:
For further information on the webinars or podcasts visit www.boehringer-academy.co.uk or contact your local Boehringer Ingelheim territory manager.
The survey, conducted among 130 veterinary professionals around the UK, including vets, nurses, receptionists and practice managers, revealed that on-demand video-based CPD ranked as the top choice of learning platform for 47% of respondents, while online text-based learning was next at 22%.
15% preferred in-person workshops and 10% in-practice training.
Meanwhile, only 6% preferred live lunchtime or evening webinars, and only 1% event lectures.
The survey identified that the most popular non-clinical CPD topics were complaint management (57%), communication (43%) and customer service (44%).
Barriers to the more widespread adoption of online learning platforms within practices were cost (70%) and a lack of time for CPD completion (80%) as a significant challenge.
Emma Barnes, Managing Director for Veterinary at Agilio, said: “The veterinary workforce is stretched and finding time to attend in-person CPD can be challenging.
"Flexible online solutions that accommodate busy schedules empower vets, nurses and the wider practice team to fulfil their CPD requirements whenever and wherever they choose.”
https://agiliosoftware.com
Vétoquinol, manufacturer of Epiphen (phenobarbital), for the control of epilepsy in dogs, has announced the launch of a new starter pack for clients that are embarking on treatment.
The starter packs contain a variety of support materials designed to help owners better understand the condition and its treatment. They sit alongside other support given by the company, which includes an 'Ask the Expert' helpline through which Epiphen veterinary customers can speak to a neurology specialist at The Animal Health Trust in Newmarket, where Vetoquinol sponsors a neurology clinician.
Abbie King, Product Manager for Epiphen, said: ''Our 'Ask the Expert' helpline is a successful service that has been running for several years. 30% of the calls to Vetoquinol's technical team relate to this challenging condition meaning there are few queries our technical team have not tackled before. If extra help is necessary we have an excellent working relationship with The Animal Health Trust and regularly refer cases to them for further advice. We are very proud of this service and are delighted to be able to continue to provide this helpline for our Epiphen clients.''
To use the 'Ask the Expert' service, or order the support materials, ring 0800 1698197. Alternatively visit: www.vetoquinol.co.uk or www.epiphenonline.co.uk.
Direct Line has revealed the results of a small survey which found that 78% of veterinary surgeons had treated pets for ingesting human medicines in the last year.
100 vets took part in the study, of which 28% reported that they had cases where owners had deliberately given their pet human medication in an attempt to help them. Some vets described incidents of owners believing paracetamol will help conditions like arthritis and limping. In one case an owner gave their cat a quarter of paracetamol every day in an attempt to stop its pain, which instead resulted in the cat dying.
The most common types of medication ingested were:
In total, the veterinary surgeons who took part in the survey reported 243 cases of accidental ingestion of human medicines. The majority (76%) of cases involved dogs. However incidents involving cats, rabbits and guinea pigs were also reported.
Zoetis (maker of Cerenia, the anti-emetic) is using social media for its latest campaign to remind owners that vets have a solution for dogs that suffer from travel sickness.
The company highlights research which shows the problem is more common than one might think, with 62% of dogs experiencing travel sickness for the first time as puppies. What's more, 1/3rd of owners say they would travel with their dogs more often if they didn't get car sick.
Stephanie Smith, Marketing Manager for Cerenia said: "While less than half of vets in the UK report seeing at least one canine motion sickness case each month, we know that over one third (34%) of dogs that travel experience motion sickness. That's a lot of opportunity for vets to provide pets and owners with some relief."
To spread the word, the company has set up an educational microsite: www.nonstoptravelfun.co.uk which it is now promoting with an online social media campaign, including twitter #nonstoptravelfun and targeted bloggers and pet sites. The company has also been advertising the microsite on Facebook and Google, which I'm told has driven thousands of visitors over the past fortnight.
Stephanie added: "Motion sickness can impact the whole family, making travelling an unpleasant experience. Our new campaign aims to raise awareness for the issue and encourage pet owners to seek veterinary help for the problem, so they can enjoy non-stop travel fun, without the sickness."
The RCVS has announced the candidates standing in the RCVS Council and Veterinary Nurses Council elections this year and is inviting veterinary surgeons and nurses to put their questions to them directly for a video reply.
There are eleven candidates standing for election to RCVS Council in 2015. Overall there are six men and five women, which include two existing Council members eligible for re-election and nine new candidates. They are:
Three veterinary nurses are standing in this year's VN Council elections, including one existing VN Council member eligible for re-election. They are:
Ballot papers and candidates' details are due to be posted to all veterinary surgeons and veterinary nurses eligible to vote during the week commencing 16th March, and all votes must be cast, either online or by post, by 5pm on Friday, 24 April 2015.
Once again the College is inviting members of both professions to 'Quiz the candidates' by putting their questions directly to all those standing for election. Each candidate will then be invited to choose two questions to answer from all those received, and produce a video or audio recording of their answers. All recordings will be published on the RCVS website on Thursday 19 March.
Vets and nurses should email their question (NB one per person) to vetvote15@rcvs.org.uk or VNvote15@rcvs.org.uk, or post it on twitter using the hashtags #vetvote15 or #VNvote15, respectively, by midday on Monday 9 March.
Gordon Hockey, RCVS Registrar said: "It's important that members of the veterinary professions choose who they want to sit on their governing Councils, so we always try to make the elections as interesting and engaging as possible.
"This year, we hope the provision of short videos, to accompany the usual written information, will encourage people to find out a little more about all those standing for election, and then use their vote."
In 2019, Jennifer Dykes won the ‘All creatures great and small’ category with her picturesque image of a misty UK mountainside and flock of sheep, entitled ‘Conversations at Dawn’.
This year’s award is split into three categories which focus on images that capture the human-animal bond in day-to-day veterinary work, as well as photos of pets or wildlife taken outside of the working environment.
Submissions for each category can be taken on a phone or a high-spec camera, and should take into account responsible animal interaction, and positive animal health and welfare.
The three categories are:
The winner or each category will get £250 worth of John Lewis vouchers and the plan is for the winning images, along with the highly commended entries, to be displayed at BVA Live on 24 – 25 June 2021.
BVA President, James Russell said: “The BVA Veterinary Photographer of the Year Award is something that we all look forward to, and the incredible array of eye-catching photos taken by people from across the veterinary community never ceases to impress me.
“In view of the current circumstances, we have introduced a new category: ‘A vet’s life in lockdown’, which we hope will produce some interesting documentation of how the profession has fared against a very challenging backdrop, like no other.
“Whether you’re a semi-professional photographer or a casual snapper, we encourage you to enter and showcase your daily interactions with animals either at work or play, or your skill at capturing wildlife at its most beautiful, even if it is in your back garden, or on the windowsill.”
The competition is open to all current BVA members. Membership must be active at the time of entering. It will be judged by BVA officers among others. Entries will close on 8 March 2021 and winners will be announced in April.
For more information and to submit your entry, visit: https://www.bva.co.uk/membership/photo-competition/.
TR Biosurgical will be officially launching its new surgical treatment for canine glaucoma at the American College of Veterinary Ophthalmologists annual conference in Chicago at the start of November.
TR-ClarifEYE is an sub-scleral implant placed in the eye in a procedure that takes around 30 minutes.
TR Biosurgical CEO Craig Woods DVM said: "TR-ClarifEYE is made from new silicone substrate subjected to a unique process which reduces fibrosis and enhances healing."
"Until now, the primary treatment options for canine glaucoma have been laser surgery, cryosurgery, evisceration or enucleation. Certain procedures can be either complicated and expensive, or fail to save the eye. Previous implants have met with only limited success, and TR-ClarifEYE appears to overcome many of the problems with glaucoma implants."
"This new implant is a relatively easy surgical approach. It has limited post-op complications. It seems to provide long term glaucoma management in the majority of patients, most of which are able to reduce medications."
For more information about TR-ClarifEYE, visit: http://www.petglaucoma.com
Practitioners interested in learning more about this procedure, click here and 'start conversation' with Craig
The company says ligation clips, used to clamp vessels, have been used in complex surgeries on humans (including heart surgeries) since the 1980’s, but have only been introduced in veterinary practice in recent years.
Vet Direct has been showcasing the clips at the recent BSAVA and AVA shows, and says it has been surprised at the level of interest in the product.
Leon Wright, managing director at Vet Direct, said: "The ligation clips caused a big noise at our recent events, which is probably down to the benefits they offer. Not only are they quicker and easier, you get immediate vessel closure which reduces the amount of time a patient has to endure under general anesthetic. I’m confident that they’ll be a great help to all veterinary surgeons."
The company says it has already seen several clients make use of the clips, most frequently in common surgeries such as splenectomies and cholecystectomies.
For more information, visit www.vet-direct.com or call 0800 068 3300.
John said: "This is a great opportunity to raise awareness for what is a very serious problem in our profession - we all know someone within the veterinary community who has had mental health problems - and I am very proud that it is a strong community trying to tackle this issue.
"But it is not just about one day – we can’t forget about it for the rest of the year. We all live extremely busy lives and if we are not functioning as people, we are not going to function as professionals."
John says veterinary professionals must take a balanced and holistic view of their lives and develop strong teams at local, regional, national and even international level, to build resilience in dealing with stress and dispelling the stigma about mental illness that may prevent people seeking help.
Mental ill-health will affect one in four people over the next 12 months[i] and in England, one in six people experience a common mental health problem (such as anxiety and depression) in any given week[ii]. There are particular issues within the veterinary profession, with higher than average rates of suicide, and patterns of distress, anxiety and depression, among other illnesses.
The BSAVA will launch a new ‘Beyond the Clinics’ personal development stream at Congress next April, including a non-clinical series of lectures on physical and mental health, and, with RCVS, it hosts a series of Mind Matters CPD courses across all 12 regions – all of which were sold out in 2016.
John added: "I’m looking forward to inviting colleagues to Beyond The Clinics on the Sunday of Congress, which is a great opportunity for the whole profession to think more deeply about how we look after each other, by increasing knowledge about mental wellbeing, building resilience in dealing with stress and dispelling the stigma about mental illness that may prevent people seeking help.
"I’m also very proud of the BSAVA’s involvement in the Mind Matters initiative, set up by the Royal College of Veterinary Surgeons. All 12 of our regions hosted sold out courses during 2016, which is part of the profession’s response to research showing that the stress of working in modern veterinary practices has taken a heavy toll on the mental wellbeing of many staff."
Limited places are available for the BSAVA’s Mind Matters regional meetings – more information is available at www.bsava.com/Education/CPD/Mind-Matters
The meetings provide training for all members of the practice team to help them recognise any signs of mental problems in their colleagues – and, perhaps, in themselves. The training aims to help individuals know how to communicate with people they are concerned about and offers tips on stress management and staying well.
John, who has suffered mental health difficulties himself, says it is important to reach out and respond as a profession to this serious problem.
"My main advice is to be aware of others, be supportive, understand and appreciate them, notice when someone isn’t acting normally, and also remember that you are in a team together with people to talk to and you should do that. You can’t take stress away completely but you can’t put everything on the practice owner, this is a whole team responsibility – upwards, sidewards and downwards."
Bringing together people working at the cutting edge of small animal and equine osteoarthritis treatment with the companies driving technology, supplies and services, the Veterinary Osteoarthritis Congress is open to both VOA members and non-members, including veterinary surgeons, nurses, physiotherapists and others engaged in hydrotherapy and rehabilitation.
Day 1 has two small animal streams – session headings include ‘Managing OA’ and ‘Dealing with chronic pain’; and an equine stream looking at ‘Multidisciplinary management of OA’, ‘OA treatment options’ and ‘Unusual presentations’.
On day 2, ‘Biomodulation in OA’, ‘Working dogs’, ‘Mobility clinic’, and ‘Feline OA focus’ will run alongside sessions on ‘Rehab in action’, ‘Surgery in OA’ and ‘Dietary supplements’.
There’ll also be case presentations and interactive sessions on both days, with demonstrations and lectures from some of the leading firms.
Seven sessions in each stream offers two days of CPD.
After the first day’s sessions there’ll be a happy hour followed by a gala dinner in the Kings Hall. The event is being sponsored by Animalcare (Platinum), TVM UK and the Canine Hydrotherapy Association (Gold) with more to be announced soon.
Professor Stuart Carmichael, co-founder and director of the VOA, said: “Exciting developments are happening in veterinary OA, so we felt now is the right time to put this event on.
"There’s nothing specialist about osteoarthritis treatment and management: every small animal and equine practice deals with OA every day.
“There’s a real need and enthusiasm for bringing the latest thinking to as wide an audience as possible, so VOACON offers sessions for all members of the practice, whatever their interest is, along with rehab and physio teams.
"It’s actually been pretty difficult fitting everything in, but we’re confident we’ve got a great programme offering real, practical CPD that will benefit practices, their clients and their patients.”
Delegate rates for VOA members are:
Non-members (who can join the VOA when booking to qualify for members’ rates):
Rates include a hot buffet lunch, congress book and CPD certification.
To book or to download the programme, visit www.vet-oa.com/voacon.
For the study1, which was conducted from March 2011 to August 2021, the cases of 50 puppies aged 3 to 6 months with unicondylar fractures were reviewed.
The sample included 30 fractures in 29 dogs treated with transcondylar bone screws and K-wires.
All fractures healed successfully.
The study included 24 male and 26 female puppies, with French Bulldogs representing 50% of the cases, ages ranging from 11 to 30 weeks and bodyweight varying from 1.5 to 16.9 kg, with a median of 5.5 kg.
Short-term outcomes were excellent in 77% of cases and good in 23%.
No catastrophic failures occurred, and the four complications encountered were resolved with further minor surgery.
The author says that while recent studies have raised concerns about the stability of using K-wires, rather than bone plates, this one suggests that for puppies at least, the combination of a transcondylar bone screw and K-wire is effective.
The incidence of implant-related complications was lower than in adult dogs, and the short-term outcomes were excellent or good in all cases with follow-up data.
The research underscores the need for further multicentre studies with longer-term follow-up to confirm these findings and compare them with other fixation techniques.
However, this study concludes that while epicondylar plates have become accepted practice for adult dogs with such fractures, they may not be necessary for puppies aged 3 to 7 months.
Study in full: https://cgrp01mstr8u1x2prod.dxcloud.episerver.net/globalassets/stock-images/humeral-condylar-paper---weighbridge-referral-centre---cvs.pdf
www.weighbridgevets.co.uk
Reference
VetCell Bioscience has become the first UK-based stem cell centre to be authorised under the Veterinary Medicines Regulations.
Following a rigorous series of inspections and reports by Good Manufacturing Practice (GMP) Inspectors VetCell, in conjunction with their UK laboratory partner Biobest, were officially authorised as an equine stem cell centre on 1 October 2009.
David Mountford, Chief Operating Officer of VetCell Bioscience said: "To have received formal authorisation so swiftly reflects the high standard of our operation and our ability to lead the field in the increasingly competitive sector of stem cell technology."
Stem cell therapy involves implanting millions of the animal's own stem cells and autologous growth factors directly into the injured tendon or ligament. The service VetCell Bioscience offers is the collection, storage, processing and supply of stem cells suitable for administration back into the donor animal.
According to the company, there is considerable interest from the human sector and studies in human medicine, for the treatment of Achilles tendinopathies, could begin as early as next year.
Vetoquinol, makers of Sedalin (acepromazine), has published a free clipping guide for horse owners.
The company says the launch of the guide has been timed to coincide with the horse clipping season, when owners may be considering sedating horses to make things safer for themselves and their horses.
The guide refers owners to their veterinary surgeon for professional advice if sedation is appropriate.
The company has also produced promotional practice posters: ' Less Stress more Success'
For your poster and accompanying guides, contact your Vetoquinol Territory Manager or Teleservices directly on 01280 825424. You may also wish to put a link to a downloadable version of the guide on your practice website: http://www.vetoquinol.co.uk/clippingguide.pdf
Sheila Wills BSc BVetMed CertSAM DipECVIM-CA MRCVS, specialist in internal medicine, has joined Wey Referrals, the Surrey-based multi-disciplinary veterinary referral practice.
Professor John Innes, Referral Director at CVS (of which Wey Referrals is a part) said: "We are delighted to welcome Sheila to our specialist team at Wey Referrals. Her experience and knowledge will further strengthen the service we offer and her appointment is another important step in the development of our referral team in the South East. Attracting the highest calibre talent is important to CVS because we want to build a referral team, whose members are not only clinically excellent but who also possess first rate communication and inter-personal skills."
Sheila said: "I am excited to be joining the CVS specialist team and look forward to working with like-minded colleagues who are passionate and dedicated to providing the highest level of patient care and client communication. I am delighted to be able to offer a specialist internal medicine service in both feline and canine medicine and look forward to offering a comprehensive service to CVS clients and expanding the internal medicine service further in the future."
Sheila graduated from the Royal Veterinary College in 1998 and spent five years in small animal practice before undertaking an FAB Residency in Feline Medicine at the University of Bristol.
Shortly after her residency, she was appointed Head of Small Animal Medicine and the Feline Centre at the Animal Health Trust where she was based for two years before moving to a major veterinary laboratory in December 2009. She recently returned to the University of Bristol as a teaching fellow in feline medicine.
Sheila acquired her ECVIM Diploma in Internal Medicine in September 2010 and is a Recognised European Veterinary Specialist in Internal Medicine. She became an RCVS Recognised Specialist in Feline Medicine in March 2012 and enjoys all aspects of feline medicine with a specialist interest in feline renal and ureteric disease. She is a member of the ICC Feline Expert Panel and an editorial board member for the Journal of Feline Medicine and Surgery.
The Animal Health Trust is appealing to veterinary surgeons and nurses to encourage clients who keep their horses on premises that have been affected by Equine Grass Sickness to sign up to the second year of its nationwide EGS vaccine trial.
Equine Grass Sickness (EGS) occurs predominantly in Europe, with Britain experiencing the highest incidence worldwide. In 2014, 59 cases of EGS were reported through the EGS Surveillance Scheme, but it is likely that this represents only a fraction of cases occurring annually throughout Britain.
Almost all cases of EGS occur in horses with access to grazing. The AHT says there is growing scientific evidence to suggest that the disease may be caused by the bacterium Clostridium botulinum type C, commonly found within soil and capable of producing neurotoxins to which horses are particularly sensitive. EGS occurs when a combination of risk factors trigger the production of these toxins within the horse's intestinal tract, causing damage to the nervous system and paralysis of the gut.
As similar equine diseases such as tetanus and botulism can be prevented by vaccination, it is theoretically possible that a vaccine could prevent EGS. To this end the AHT, in collaboration with the Universities of Edinburgh, Liverpool and Surrey launched the EGS field vaccine trial in 2014 in order to establish whether a vaccine could indeed be effective in reducing the risk of the disease. The trial is funded by a number of sources including Neogen Corporation; Animal Welfare Foundation; Horserace Betting Levy Board; Racing Foundation; Moredun Foundation Equine Grass Sickness Fund; Hong Kong Jockey Club; The British Horse Society and the EB Moller Charitable Trust.
Now entering its second year, the EGS vaccine trial involves enrolled horses and ponies receiving either a course of the C. botulinum type C toxoid vaccine or an inactive placebo, as well as an annual booster. The incidence of EGS is monitored throughout the trial to determine the efficacy of the vaccine, and enrolled horses and ponies are closely monitored through regular follow-ups for the duration of the trial.
With 60% of EGS cases occurring during April - June, the highest risk season for EGS is fast approaching. The AHT is appealing to owners who keep their horses on premises that have had at least one case of EGS in the past three years to enrol their horse in the vaccine trial and provide an invaluable contribution to this pioneering research prior to these high risk months. Veterinary practices with clients who fit this description are asked to help the recruitment process by encouraging suitable cases to sign up to the trial.
Dr Jo Ireland, the AHT's Equine Grass Sickness Research Co-ordinator, said: "We have been delighted with the overwhelmingly positive response to the EGS vaccine trial and many owners have welcomed the chance to be a part of such important research. We don't want any eligible horse owners to miss out on the opportunity to contribute towards a potential breakthrough in the prevention of EGS, so we are encouraging more owners to enrol their horses on the trial this year."
To find out more about the vaccine trial or how clients can enrol horses and ponies, visit the AHT's dedicated EGS website www.equinegrasssickness.co.uk or email equinegrasssickness@aht.org.uk.
The new tool is part of a package that also includes posters and SMS texts to support veterinary practices in raising awareness of gastric ulcers to horse owners.
Equine Gastric Ulcer Syndrome (EGUS) is a serious and common condition and any type of horse can be at risk.1 EGUS can have a profound impact on a horse’s condition and performance and can be life threatening in foals. It is a challenging condition to diagnose as the clinical signs are often vague and not always present.1
Gastroscopy is the only method currently available for a definitive diagnosis. Of the two types of disease equine squamous gastric disease is graded on a numeric scale with 1 being the least severe and 4 being the most serious. Equine glandular gastric disease can be very varied in terms of location and type so grading this disease on a score system is no longer recommended. Instead it is now usually described in terms of location, severity and appearance.2
The new tool has been designed to help vets to map the area affected by gastric disease and record the details in an accessible format. This information, together with treatment and management recommendations, can be shared easily with the client. Posters explaining gastric ulceration have been designed to help increase awareness and understanding of EGUS amongst horse owners.
Zoetis says effective treatment usually involves a combination of management and medical treatments. UlcerGold is indicated to treat and prevent the recurrence of gastric ulcers in horses, administered once-daily for 28 consecutive days at the full dose of 4mg/kg bodyweight followed by the reduced dose of 1mg/kg bodyweight for a further 28 days.3 It contains omeprazole, a proton pump inhibitor that suppresses gastric acid secretion.3,4 One syringe contains enough UlcerGold for a daily dose for a horse weighing up to 700kg. It can be used for foals as young as four weeks of age that weigh over 70kg and for breeding stallions.
The session will be conducted in the style of the BBC Radio 4 Moral Maze discussion programme, with panelists and witnesses arguing for and against the viewpoint corporatisation is inevitable and will benefit vets and their clients.
Moderated by Madeleine Campbell, Keith Chandler and Karl Holliman will argue for corporatisation and Andrew Harrison and Tim Greet will be against. They will call upon a series of 'witnesses' for detailed questioning before the topic is more broadly debated.
CVS, the UK’s biggest veterinary group now owns more than 410 veterinary practices, of which over 30 are specifically equine or mixed practices.
The latest equine acquisitions include Bell Equine, a one-site Equine Referral Hospital in Kent, in January 2017 and Severn Edge Veterinary Group, a mixed practice with 12 sites in Shropshire, including a six-vet dedicated equine practice, in April 2017.
One line of argument says that the commercial and business advantages of a corporate, together with their scale and diversity, can give veterinary surgeons greater potential for a more flexible career path and advancement within the industry, and a more sustainable working career in equine practice.
On the flip side, there's the removal of any opportunity to buy into ownership, reduced decision-making ability because of adherence to corporate procedures, extra paperwork, longer approval processes and an increased emphasis on the bottom line.
David Mountford, Chief Executive of BEVA said: "The auditorium is usually full to bursting for our Moral Maze sessions because they bring a broader and more engaging dimension to important topics. The statement Corporatisation of equine practices is inevitable and will benefit vets and their clients is bound to generate some stimulating and possibly heated debate."
This year's BEVA Congress will be held at Liverpool Arena Convention Centre, and anyone who registers before 3rd August will receive significantly reduced booking fees.
For more information, visit: www.beva.org.uk.
The Congress, which is organised by Improve International, has separate streams for small animal medicine and small animal surgery and a dedicated veterinary nursing stream.
There will also be an exhibition of the latest innovations in veterinary products and services running alongside the lectures.
Helen Richmond, Head of Publishing at Improve said: “While technological innovation has made online congresses much more engaging and accessible over the last year, we felt the time was right to bring Vets North back in a face-to-face environment. Many of our previous delegates have already told us how much they are looking forward to being able to learn and enjoy some social time together again.
“As usual this year’s programme will include presentations and lectures from global experts, who will give advice and share knowledge that can be implemented in practice immediately. We would like to thank Elanco as our lead sponsor of this year’s Vets North and we also thank our other partners and sponsors for their support and loyalty during this difficult year.”
"Naturally, keeping delegates safe is our highest priority so we are working with the venue to ensure that the Government’s recommendations are implemented to the full and that Haydock Park is a COVID-secure venue.”
Early Bird tickets are available until the end of June.
For more information visit www.vetsnorth.com or call 01793 20805.
Whilst you're there, the company will doubtless use the opportunity to bend your ear about how its technology can save time, drive revenue, and strengthen patient care.
Still, all in a good cause, and the company says it expects to be making a significant donation towards supporting members of the veterinary community who are experiencing financial and mental health challenges.
ezyVet Chief Growth Officer Pete Brown said: ““As innovators in the veterinary software space, we’re passionate about bettering the lives of veterinary professionals and we recognise the critical work Vetlife is doing to support the hard-working veterinary community.
"We’re going to be donating £1 to Vetlife for every person that visits the ezyVet booth at the London Vet Show, so we encourage everyone to come down and help us support this very worthwhile cause.”